Senior Director of Government Relations
Virta Health$187,900 - $216,000/year
Full Time
Senior (5 to 8 years)
Sr. Director, Investor Relations at Gilead Sciences
Foster City, California, United States
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
BiopharmaceuticalIndustries
Requirements
- Excellent attention to detail
- Very strong verbal and interpersonal communication skills
- Expert in Excel and PowerPoint
- Ability to understand and interpret financial statements
Responsibilities
- Manage quarterly earnings process and deliverables including script, deck and Q&A materials
- Design and execute an impactful investor engagement program, including investor conferences, non-deal roadshows, analyst days, annual meeting, on-site meetings and other events
- Deliver concise and impactful communications to support Gilead participation at scientific conferences and pre-clinical or clinical data updates
- Support executives’ participation at investor conferences, including preparation of Q&A materials and travel to conferences
- Conduct peer and competitive analysis of clinical pipelines and business models
- Innovate and evolve IR program but always in full compliance with all regulatory requirements surrounding investor communications
- Deliver highly responsive and accurate communications to in-bound inquiries from all stakeholders (sell-side, buy-side, retail, employees, executives)
- Manage a team of five
- Serve as the primary contact for coverage and targeted sell-side analysts and for most buy-side holders and targets
- Interact routinely with Gilead’s senior executives
Skills
Key technologies and capabilities for this role
Questions & Answers
Common questions about this position
What is the salary for the Sr. Director, Investor Relations position?
This information is not specified in the job description.
Is this a remote position or does it require working on-site?
The role is based at Gilead's Foster City Campus.
What are the key responsibilities of this role?
The Sr. Director manages the day-to-day investor relations program, serves as primary contact for sell-side analysts and buy-side holders, manages a team of five, and handles quarterly earnings processes including scripts, decks, and Q&A materials.
What is the team structure for this position?
The Sr. Director will manage a team of five and reports to the Senior Vice President of Treasury and Investor Relations.
What is the company culture like at Gilead?
Gilead emphasizes collaboration, determination, a close community where every individual matters, ongoing development opportunities, and creating an inclusive environment where employees feel developed and empowered.
Gilead Sciences
Develops and commercializes biopharmaceuticals
About Gilead Sciences
Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.
Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees
Benefits
Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options
Risks
Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.
Differentiation
Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.
Upsides
Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.
Related Jobs
RemoteRemoteSenior Consultant Relations Manager (Southeast)
CalmSalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
RemoteConsultant Relations VP
Garner HealthSalary not specified
RemoteHead of Investor Applications
YipitDataSalary not specified
RemoteDeveloper Relations Lead
TimescaleSalary not specified
- Full Time
- Senior (5 to 8 years)
RemoteHospital Pharmaceutical Sales Specialist - Gulf Coast
Azurity PharmaceuticalsSalary not specified
RemoteAnalyst Relations Director
TwilioSalary not specified
- Full Time
- Expert & Leadership (9+ years)
RemoteIndustry Architect, Life Sciences
Snowflake$116,000 - $156,100/year
- Full Time
- Expert & Leadership (9+ years)
RemoteSenior Director, Marketing Communications
SaviyntSalary not specified
RemoteInvestor Accounting Analyst
ValonSalary not specified
- Full Time
- Mid-level (3 to 4 years)
RemoteClient Relations Specialist, Private Risk
Foundation Risk PartnersSalary not specified
- Full Time
- Entry Level & New Grad
RemoteCorporate Finance Lead
ClassDojoSalary not specified
- Full Time
- Expert & Leadership (9+ years)
RemoteUtility Relations Manager
Flock SafetySalary not specified
RemoteSales Director, Life Sciences
WheelSalary not specified